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Abstract 
PubMed® is an essential resource for the medical domain, but useful concepts are either difficult 
to extract or are ambiguated, which has significantly hindered knowledge discovery. To address 
this issue, we constructed a PubMed knowledge graph (PKG) by extracting bio-entities from 
29 million PubMed abstracts, disambiguating author names, integrating funding data through 
the National Institutes of Health (NIH) ExPORTER, collecting affiliation history and 
educational background of authors from ORCID®, and identifying fine-grained affiliation data 
from MapAffil. Through the integration of the credible multi-source data, we could create 
connections among the bio-entities, authors, articles, affiliations, and funding. Data validation 
revealed that the BioBERT deep learning method of bio-entity extraction significantly 
outperformed the state-of-the-art models based on the F1 score (by 0.51%), with the author 
name disambiguation (AND) achieving a F1 score of 98.09%. PKG can trigger broader 
innovations, not only enabling us to measure scholarly impact, knowledge usage, and 
knowledge transfer, but also assisting us in profiling authors and organizations based on their 
connections with bio-entities. The PKG is freely available on Figshare 
(https://figshare.com/s/6327a55355fc2c99f3a2, simplified version that exclude PubMed raw 
data) and TACC website (http://er.tacc.utexas.edu/datasets/ped, full version). 
 
Background and Summary  
Experts in healthcare and medicine communicate in their own languages, such as SNOMED 
CT, ICD-10, PubChem, and gene ontology. These languages equate to gibberish for laypeople, 
but for medical minds, they are an intricate method of transporting important semantics and 
consensus capable of translating diagnoses, medical procedures, and medications among 
millions of physicians, nurses, and medical researchers, thousands of hospitals, hundreds of 
pharmacies, and a multitude of health insurance companies. These languages (e.g., genes, drugs, 
proteins, species, and mutations) are the backbone of quality healthcare. However, they are 
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deeply embedded in publications, making literature searches increasingly onerous because 
conventional text mining tools and algorithms continue to be ineffective. Given that medical 
domains are deeply divided, locating collaborators across domains is arduous. For instance, if 
a researcher wants to study ACE2 gene related to COVID-19, he or she would like to know the 
following: which researchers are currently actively studying ACE2 gene, what are the related 
genes, diseases, or drugs discussed in these articles related to ACE2 gene, and with whom could 
the researcher collaborate? This is a strenuous position to be in, and the aforementioned 
problems diminish the curiosity directed at the topic.  
Many studies have been devoted to building open-access datasets to solve bio-entity 
recognition problems. For example, Kai et al.1 used a conditional random field classifier-based 
tool to recognize the named entities from PubMed and PubMed Central. Bell et al.2 performed a 
large-scale integration of a diverse set of bio-entities and their relationships from both bio-entity 
datasets and PubMed literature. Although these open-access datasets are predominantly about 
bio-entity recognition, researchers have also been interested in extracting other types of entities 
and relationships in PubMed, including the mapping of author affiliations to cities and their 
geocodes3,4, author name disambiguation5 (AND), and author background information 
collections6. Although the focus of previous research has been on limited types of entities, the 
goal of our study was to integrate a comprehensive dataset by capturing bio-entities, 
disambiguated authors, funding, and fine-grained affiliation information from PubMed 
literature. 
Figure 1 illustrates the bio-entity integration framework. This framework consists of two 
parts: (1) bio-entity extraction, which contains entity extraction, named entity recognition 
(NER), and multi-type normalization, and (2) integration, which connects authors, ORCID, and 
funding information. 
 
 
Figure 1. Bio-entity integration framework for PKG 
 
The process illustrated in Figure 1 can be described as follows. First, we applied the high-
performance deep learning method Bidirectional Encoder Representations from Transformers 
for Biomedical Text Mining (BioBERT) 7,8 to extract bio-entities from 29 million PubMed 
abstracts. Based on the evaluation, this method significantly outperformed the state-of-the-art 
methods based on the F1 score (by 0.51%, on average). Then, we integrated two existing high-
quality author disambiguation datasets: Author-ity5 and Semantic Scholar9. We obtained the 
disambiguated authors of PubMed articles with full coverage and quality of 98.09% in terms of 
the F1 score. Next, we integrated additional fields from credible sources into our dataset, which 
included the projects funded by the National Institutes of Health (NIH) 10, the affiliation history 
and educational background of authors from ORCID6, and fine-grained region and location 
information from the MapAffil 2016 dataset11. We named this new interlinked dataset “PubMed 
Knowledge Graph” (PKG). PKG is by far the most comprehensive, up-to-date, high-quality 
dataset for PubMed regarding bio-entities, articles, scholars, affiliations, and funding 
information. Being an open dataset, PKG contains rich information ready to be deployed, 
 3 / 19 
 
facilitating the effortless development of applications such as finding experts, searching bio-
entities, analyzing scholarly impacts, and profiling scientist’s careers.  
Methods 
Bio-Entity Extraction 
The bio-entity extraction component has two models: (1) an NER model, which recognizes the 
named entities in PubMed abstracts based on the BioBERT model7, and (2) a multi-type 
normalization model, which assigns unique IDs to recognize biomedical entities. 
 
(1) Named Entity Recognition (NER). The NER task recognizes a variety of domain-specific 
proper nouns in a biomedical corpus and is perceived as one of the most notable biomedical 
text mining tasks. In contrast to previous studies that have built models based on long short-
term memory (LSTM) and conditional random fields (CRFs)12,13, the recently proposed 
Bidirectional Encoder Representations from Transformers (BERT)14 model achieves excellent 
performance for most of the NLP tasks with minimal task-specific architecture modifications. 
The transformers applied in BERT connect the encoders and decoders through self-attention 
for greater parallelization and reduced training time. BERT was designed as a general-purpose 
language representation model that was pre-trained on English Wikipedia and BooksCorpus. 
Consequently, it is incredibly challenging to maintain high performance when applying BERT 
to biomedical domain texts that contain a considerable number of domain-specific proper nouns 
and terms (e.g., BRCA1 gene and Triton X-100 chemical). BERT required refinement, so 
BioBERT—a neural network-based high-performance NER model—was developed. Its 
purpose is to recognize the known biomedical entities and discover new biomedical entities.  
First, in the NER component, the case-sensitive version of BERT is used to initialize 
BioBERT. Second, PubMed articles and PubMed Central articles are used to pre-train 
BioBERT’s weights. The pre-trained weights are then fine-tuned for the NER task. While fine-
tuning BERT (BioBERT), we use WordPiece tokenization15 to mitigate the out-of-vocabulary 
issue. WordPiece embedding is a method of dividing a word into several units (e.g., 
Immunoglobulin divided into I ##mm##uno ##g ##lo ##bul ##in) and expressing each unit. 
This technique is effective at extracting the features associated with uncommon words. The 
NER models available in BioBERT can predict the following seven tags: IOB2 tags (i.e., Inside, 
Outside, and Begin)16, X (i.e., a sub-token of WordPiece), [CLS] (i.e., the leading token of a 
sequence for classification), [SEP] (i.e., a sentence delimiter), and PAD (i.e., a padding of each 
word in a sentence). The NER models were fine-tuned as follows8: 
 
𝑝(𝑇𝑖) = 𝑠𝑜𝑓𝑡𝑚𝑎𝑥(𝑇𝑖𝑊
𝑇 + 𝑏)𝑘 , 𝑘 = 0,1, … ,6     (1) 
 
where k represents the indexes of seven tags {B, I, O, X, [CLS], [SEP], PAD}, p is the 
probability distribution of assigning each k to token i, and 𝑇𝑖 ∈ 𝑅
𝐻
 is the final hidden 
representation, which is calculated by BioBERT for each token i. H is the hidden size of 𝑇𝑖, 
𝑊 ∈ 𝑅𝐾×𝐻 is a weight matrix between k and 𝑇𝑖, K represents the number of tags and is equal 
to 7, and b is a K-dimensional vector that records the bias on each k. The classification loss L 
is calculated as follows: 
𝐿(𝛩) = −
1
𝑁
∑ 𝑙𝑜𝑔(𝑝(𝑦𝑖|𝑇𝑖; 𝛩)
𝑁
𝑖=1    (2) 
where 𝛩 represents the trainable parameters, and N is the sequence length. 
First, a tokenizer is applied to words in a sentence on a dataset with labels in the CoNLL 
format17. The WordPiece algorithm is then applied to the sub-words of each word. 
Consequently, BioBERT is able to extract diverse types of bio-entities. Furthermore, an entity 
or two entities with frequently-occurring token interaction will be marked with more than one 
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entity type span (26.2% for all PubMed abstracts). Based on the calculated probability 
distribution, we are able to choose the correct entity type when entities are tagged with more 
than two types according to the probability-based decision rules8. 
 
(2) Multi-Type Normalization. Because an entity may be referred to by several synonymous 
terms (synonyms), and a term can be polysemous if it refers to multiple entity types (polysemy), 
we require a normalization process for the extracted entities. However, it is a daunting challenge 
to build a single normalization tool for multiple entity types because there exist various 
normalization models that depend on the type of entity. We addressed this issue by combining 
multiple NER normalization models into one multi-type normalization model that assigns IDs 
to extracted entities. Table 1 illustrates the statistics of the proposed normalization model.   
 
Table 1. Multi-type normalization model and dictionaries. 
Entity types Normalization 
models 
Dictionaries # of IDs # of names Avg. # of 
names  
per ID 
Gene/Protein GNormPlus Entrez Gene18 139,375 248,581 1.8 
Disease Sieve-based entity 
linking19 
MeSH20, OMIM21, SNOMED·CT22, 
PolySearch223 
32,954 172,650 5.2 
Drug/Chemi
cal 
tmChem without 
Ab3P 
MeSH20, ChEBI24, DrugBank25, US FDA-
approved drugs 
518,223 2,571,570 5.0 
Species Dictionary lookup NCBI Taxonomy 398,037 3,119,005 7.8 
Mutation tmVar 2.0 dbSNP26, Clin Var27 208,474 302,498 1.5 
Total   1,297,063 6,414,304 4.9 
  
The multi-type normalization model is based on a normalization model per entity type 
(Table 1). To improve the number of normalized entities, we added the disease names from the 
PolySearch2 dictionary (76,001 names of 27,658 diseases) to the sieve-based entity linking 
dictionary (76,237 names of 11,915 diseases). We also added the drug names from DrugBank25 
and the U.S. Food and Drug Administration (FDA) to the tmChem dictionary. Because there 
are no existing normalization model for species, we normalized species based on dictionary 
lookup. Using tmVar 2.0, we created a dictionary of mutations with normalized mutation names, 
in which a mutation with several names was assigned to one normalized name or ID. 
Author Name Disambiguation (AND) 
Despite a rigorous effort to create global author IDs (e.g., ORCID and ResearcherID), most 
articles in PubMed, particularly those before 2003 (the year in which the field ORCID was 
added into PubMed), provide limited author information with respect to last name, first initial, 
and affiliation (only for first authors before 2014). Author information is not effective meta-
data to be used directly as a unique identifier because different people may have the same names, 
and the names and affiliations of an individual can change over time. AND is essential for 
identifying unique authors. 
In recent decades, researchers have made several attempts to solve the AND problem, using 
three types of methods. The first type of method relies on manual matching of articles with 
authors by surveying scientists or consulting curricula vitae (CVs) gathered from the Internet 
28. Although this type of method ensures high accuracy, a considerable amount of investment 
in labor is required to collect and code the data, which is impractical for huge datasets. The 
second type of method uses publicly-accessible registry platforms, such as ORCID or Google 
Scholar, to help researchers identify their own publications, which produces a source of highly 
accurate and low-cost accessible disambiguation of authorship for large numbers of authors. 
However, registries cover only a small proportion of researchers29,30, which introduces a form 
of survivor bias into samples. The third type of method uses an automated approach to estimate 
the similarity of author instance feature combinations and identify whether they refer to the 
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same person. The features for automated AND include author name, author affiliation, article 
keywords, journal names31, coauthor information32, and citation patterns33. Automated methods 
typically rely on supervised or unsupervised machine learning, in which the machine learns 
how to weigh the various features associated with author names and where to assign a pair of 
author names either to the same author or to two different authors34,35. This type of method can 
potentially avoid the shortcomings of the previous two types. Moreover, automated methods 
have been improved to a high level of accuracy after years of development. 
For PubMed, automated methods are the optimal choice because they can overcome the 
shortcomings of the other two methods while simultaneously providing high-quality AND 
results for the entire dataset. Several scholars have disambiguated the authors using automated 
methods. Although the evaluations of these results have exhibited different levels of accuracy 
and coverage limitations, we believe that integrating them with due diligence can yield a high-
quality AND dataset with full coverage of PubMed articles.  
According to our investigation, a high-quality PubMed AND dataset with complete 
coverage can be obtained through the integration of the following two existing AND datasets: 
(1) Author-ity: The Author-ity database uses diverse information about authors and 
publications to determine whether two or more instances of the same name (or of highly similar 
names) on different papers represent the same person. According to the AND evaluation based 
on the method discussed in the section Technical Validation, the F1 score of Author-ity is 
98.16%, which is the highest accuracy result that we have observed. However, this dataset only 
covers authors before 2009.  
(2) Semantic Scholar: It trains a binary classifier to merge a pair of author names and use 
the pair to create author clusters incrementally. According to the AND evaluation based on the 
method discussed in the section Technical Validation, the F1 score of Semantic Scholar is 
96.94%, which is 1.22% lower than that of Author-ity. However, it has the most comprehensive 
coverage of authors. 
Because the Author-ity dataset has a higher F1 score than the Semantic Scholar dataset, 
we selected the author’s unique ID of the Author-ity dataset as the primary AND_ID. AND_ID 
is limited by time range (containing PubMed papers before 2009); however, we supplemented 
authors after 2009 using the AND result from Semantic Scholar. The following steps were 
applied: 
Step 1: Allocate the author’s unique ID to each author instance according to the Author-
ity AND results such that authors from the Author-ity dataset (before 2010) have unique author 
IDs. 
Step 2: For authors that have the same Semantic Scholar AND_ID but never appear in the 
Author-ity dataset, we generated a new AND_ID to label them. For example, author “Pietranico 
R.” published two papers in 2012 and 2013 and had two corresponding author instances. 
Because all papers that “Pietranico R.” published were after 2009, they were not covered by 
Author-ity and therefore had no AND_ID allocated by Author-ity. However, the authors 
disambiguated correctly by Semantic Scholar were allocated unique AND_IDs in Semantic 
Scholar. To maintain the consistency in labeling, we generated a new AND_ID continuing 
AND-IDs of Author-ity to label these two author instances as disambiguated by Semantic 
Scholar. 
Step 3: For author instances with a unique AND_ID in Semantic Scholar and in which 
authors (at least one) had the same Author-ity AND_ID, we allocated the Author-ity AND_ID 
to all author instances as their unique ID. For example, “Maneksha S.” published three papers 
in 2007, 2009, and 2010, and the first two author instances had unique Author-ity AND_ID. 
However, the last one had no Author-ity AND_ID because it was beyond the time coverage of 
the Author-ity dataset. Nevertheless, based on the AND results of Semantic Scholar, the three 
author instances had an identical AND_ID. Therefore, the last author instance with no Author-
ity AND_ID could be labeled with the same ID as the other two author instances.    
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Extended Multi-source Information Integration 
In addition to bio-entity extraction by BioBERT and AND, we made a considerable effort 
to integrate PubMed by extending multi-source data into PKG, which exploited the mapping 
connections between AND_ID and the PubMed identifier (PMID) to build relationships 
between different objects to provide a comprehensive overview of the PubMed dataset. These 
integrated data includes the funding data from NIH ExPORTER, the affiliation history and 
educational background of authors from ORCID, and the fine-grained region and location 
information from the MapAffil 2016 dataset. The entities and their associated relationships are 
depicted in Figure 2.  
 
 
Figure 2. Entities and relationships in PKG 
  
(1) Project Data from NIH ExPORTER 
 
NIH ExPORTER provides data files that contains research projects funded by major 
funding agencies such as the Centers for Disease Control and Prevention (CDC), the NIH, the 
Agency for Healthcare Research and Quality (AHRQ), the Health Resources and Services 
Administration (HRSA), the Substance Abuse and Mental Health Services Administration 
(SAMHSA), and the U.S. Department of Veterans Affairs (VA). Furthermore, it provides 
publications and patents citing support from these projects. It consists of 49 data fields, 
including the amount of funding for each fiscal year, organization information of the PIs, and 
the details of the projects. According to our investigation, NIH-funded research accounts for 
80.7% of all grants recorded in PubMed. 
The NIH ExPORTER dataset contains a unique PI_ID for each scholar who received NIH 
funding between 1985 and 2018, and his or her PMIDs of the published articles. Through the 
mapping of PMIDs in NIH ExPORTER to PMIDs in PubMed, 1:N connections between the PI 
and the article have been established, paving the way for investigating the article details of a 
specific PI, and vice versa. Furthermore, by mapping PI names (last name, first initial, and 
affiliation) to author names that were listed in articles supported by the PI’s projects, a 1:1 
connection between the PI and the AND_ID was established, providing a way to obtain PI-
related article information, regardless of whether the article was labeled with a project ID.  
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(2) Employment History and Educational Background Data from ORCID 
 
According to its website, “ORCID is a nonprofit organization helping to create a world in 
which all who participate in research, scholarship, and innovation are uniquely identified and 
connected to their contributions and affiliations across disciplines, borders, and time”36. It 
maintains a registry platform for researchers to actively participate in identifying their own 
publications, information about formal employment relationships with organizations, and 
educational backgrounds. ORCID provides an open-access dataset called ORCID Public 
Dataset 20186, which contains a snapshot of all public data in the ORCID Registry associated 
with an ORCID record that was created or claimed by an individual as of October 1, 2018. The 
dataset includes 7,132,113 ORCID iDs, of which 1,963,375 have educational affiliations and 
1,913,610 have employment affiliations.   
As a result of the proliferation of ORCID identifiers, PubMed has used ORCID identifiers 
as alternative author identifiers since 201337. Using the aforementioned two steps, we could 
map ORCID records to the PubMed authors. Our first step was to map the author instances in 
PubMed to an ORCID record based on the feature combinations of article DOI and author name 
(last name and first initial). Because the DOI is not a compulsory field for PubMed, we 
appended the feature combinations of article titles, journals, and author names to map the 
records between the two datasets. The result contained many 1:1 connections between a 
disambiguated author of PubMed and an ORCID record. Furthermore, 1:1 connections between 
AND_ID and ORCID iD, and 1:N connections between AND_ID and background information 
(education and employment) were established. 
   
(3) Fine-Grained Affiliation Data 
 
The MapAffil 2016 dataset3 resolves PubMed authors’ affiliation strings to cities and 
associated geocodes worldwide. This dataset was constructed based on a snapshot of PubMed 
(which included the Medline and PubMed-not-Medline records) acquired in the first week of 
October 2016. Affiliations were linked to a specific author on a specific article. Prior to 2014, 
PubMed only recorded the affiliation of the first author. However, MapAffil 2016 covered 
some PubMed records that lacked affiliations and were harvested elsewhere, such as from PMC, 
NIH grants, the Microsoft Academic Graph, and the Astrophysics Data System. All affiliation 
strings were processed using MapAffil to identify and disambiguate the most specific place 
names. The dataset provides the following fields: PMID, author order, last name, first name, 
year of publication, affiliation type, city, state, country, journal, latitude, longitude, and Federal 
Information Processing Standards (FIPs) code. 
The MapAffil 2016 dataset does have a limitation because it does not cover the PubMed 
data after 2015 (covering 62.9% affiliation instances in PubMed). Consequently, we performed 
an additional step to improve the fraction of coverage. We collected authors (who published 
their first article before 2016 and continued publishing articles after 2015) by their AND_IDs. 
The new affiliation instances of the author after 2015 succeeded their corresponding fine-
grained affiliation data from the affiliation instances before 2016 (fraction of affiliation instance 
coverage increased to 84.2%) if the author did not change affiliation. We also applied an up-to-
date open-source library Affiliation Parser4 to extract additional fine-grained affiliation fields 
from all affiliation instances, including department, institution, email, ZIP code, location, and 
country.          
Table 2 summarizes the date coverage and version information of integrated datasets and 
open-access software used to extract data.  
 
Table 2. Date coverage and version information of data sources  
Data Source Start Year End Year Version Information 
PubMed 2019 baseline files39 1781 2018 
The PubMed 2019 baseline files were released in December 
2018. It also includes 13,097 papers published after 2018 and 
majority of them are preprints. 
Author-ity dataset5 1865 2008 The dataset was generated based on PubMed 2009 baseline 
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files. It also includes AND results of 93,228 papers published 
after 2008, and majority of them are preprints. 
Semantic Scholar dataset9 1786 2019 The dataset was released on January 31, 2019. 
NIH ExPORTER dataset10 1985 2018 
The articles marked with projects span from 1981 to 2018, and 
project details cover from 1985 to 2018. The dataset was 
downloaded in June 2018. 
Employment History Data 
from ORCID6 
1913 2018 
The dataset was released on October 22, 2018. ORCID 
publishes the data once per year. 
Educational Background 
Data from ORCID6 
1913 2018 
The dataset was released on October 22, 2018. ORCID 
publishes the data once per year. 
MapAffil 2016 dataset3 1975 2017 
The dataset is based on a snapshot of PubMed taken in the first 
week of October, 2016, and was released on April 5, 2018. 
Affiliation Parser Library4 1786 2019 
Fast and simple parser for MEDLINE and PubMed Open-
Access affiliation string, which was published on March 15, 
2018. We apply it to parse multiple fields from the affiliation 
string, including department, institution, zip code, location, 
and country. 
 
Data Records 
We built PKG with bio-entities extracted from PubMed abstracts, AND results of PubMed 
authors, and the integrated multi-source information. This dataset is freely available on 
Figshare38. It contains seven comma-separated value (CSV) files named “Author_List,” 
“Bio_entities_Main,” “Bio_entities_Mutation,” “Affiliations,” “Researcher_Employment,” 
“Researcher_Education,” and “NIH_Projects”. The details are presented in Table 3. PubMed 
raw data are not included into Figshare file set because the amount of PubMed raw data is too 
large and they are not generated or altered by our methods. PubMed raw data can be freely 
downloaded from PubMed website39. We also provide download link 
(http://er.tacc.utexas.edu/datasets/ped), which contains both the PubMed raw data and PKG 
dataset to facilitate the application of PKG dataset.    
 
Table 3. Dataset details. 
File # of Lines 
# of Distinct 
PMIDs 
# of Distinct 
AND_IDs 
Short description 
Author_List 114,345,178 28,510,300 14,830,461 
CSV file containing PubMed authors and 
AND_IDs. 
Bio-entities_Main 330,394,494 18,361,409 - 
CSV file containing all types of extracted 
bio-entities by BioBERT. 
Bio-entities_Mutation 1,388,341 312,099 - 
CSV file containing additional items of 
mutations from Bio-entities_Main file. 
Affiliations 46,065,099 19,601,383 8,300,984 
CSV file containing affiliations and their 
extracted fine-grained items. 
Researcher_Employment 532,356 - 276,483 
CSV file containing employment history 
from ORCID. 
Researcher_Education 512,267 - 268,610 
CSV file containing educational background 
from ORCID. 
NIH_Porjects 12,340,431 1,790,949 102,070 
CSV file containing projects from NIH 
ExPORTER and mapping relation between 
PI_ID, PMID, and AND_ID. 
Note: In file Author_List, about 1.3 million (1.15%) author instances cannot be disambiguated because they do not exist in Author-
ity or Semantic Scholar dataset. Therefore, their AND_ID field values were set to zero. 
 
The statistics of all five types of extracted entities are presented in Table 4.  
Table 4. Statistics of extracted entities 
 Species Disease Gene / Protein Drug/Chemical Mutation 
Total number of 
extracted entities 
65,737,425 98,865,897 81,035,640 83,367,191 1,388,341 
Distinct PMIDs for 
each type 
13,717,884 12,708,292 7,914,735 9,681,294 312,099 
Distinct entities for 
each type 
84,203 36,704 25,489 134,574 208,466 
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Each data field is self-explanatory by its name, and fields with the same name in other 
tables follow the same data format that can be linked across tables. Tables 5–11 illustrate the 
field name, format, and short description of fields for each data file listed in Table 3. 
 
Table 5. Data type for records of Author_List. 
Index Format # of Lines with 
non-empty 
values 
Short description 
id Integer 114,345,178 Unique ID for each author instance. 
PMID Integer 114,345,178 Unique ID assigned by PubMed to identify PubMed articles. 
AND_ID Integer 109,245,192 Unique author ID allocated by AND.  
AuOrder Integer 114,345,178 Author order of the current author in the author list of current articles. 
LastName String 114,130,643 Last name of the current author. 
ForeName String 113,452,639 First name of the current author. 
Initials String 114,007,764 Middle initials of the current author. 
Suffix String 513,508 Suffix name of the current author. 
AuNum Integer 114,345,178 Co-author number of the current articles. 
PubYear Integer 114,345,178 Publication year of the current article. 
BeginYear Integer 109,245,192 Begin year of the current author’s first article. 
 
Table 6. Data type for records of Bio_Entities_Main. 
Index Format # of Lines with 
non-empty values 
Short description 
id Integer 330,394,594 Unique ID for each bio-entity instance. 
PMID Integer 330,394,594 Unique ID assigned by PubMed to identify PubMed articles. 
Start Integer 330,394,594 Start position of mention in an abstract. 
End Integer 330,394,594 End position of mention in an abstract. 
Mention String 330,394,594 Entity mentioned in an abstract. 
EntityID Integer 265,304,264 Normalized entity ID. 
Type String 330,394,594 Enumerated type of entity; values include species, disease, gene, drug, and 
mutation. 
 
Table 7. Data type for records of Bio_Entities_Mutation. 
Index Format # of Lines with 
non-empty values 
Short description 
Main_id Integer 1,388,341 Foreign key references from Bio-entities_Main (id). 
Mention String 1,388,341 Mutation entity mentioned in the abstract. 
MutationType String 1,388,341 Normalized entity ID. 
NormalizedName String 1,388,341 Enumerated type of entity; values include species, disease, gene, 
drug, and mutation. 
 
Table 8. Data type for records of Affiliations. 
Index Format # of Lines with 
non-empty values 
Short description 
id Integer 46,065,099 Unique ID for each affiliation. 
PMID Integer 46,065,099 Unique ID assigned by PubMed to identify PubMed articles. 
AuOrder Integer 46,065,099 Author order of the current author in the author list of the current 
article. 
AND_ID Integer 42,242,447 Unique author ID allocated by AND. 
AffiliationOrder Integer 46,065,099 Affiliation order in the affiliation list of the current author. 
Affiliation String 42,676,487 Affiliation string. 
Department String 29,438,469 The department that the author belongs to. 
Institution String 38,955,031 The institution that the author belongs to. 
Email String 8,092,262 The author’s email address. 
ZipCode String 16,573,810  The postcode of this affiliation. 
Location String 42,590,482 The address of the affiliation. 
Country String 39,536,798 The country that the author belongs to. 
City String 32,151,044 The city that the author belongs to. 
State String 31,910,547 The state that the author belongs to. 
AffiliationType String 35,706,926 Enumerated type of affiliation; values include COM, EDU, EDU-
HOS, GOV, HOS, MIL, ORG, and UNK. 
Latitude Float 36,371,281 The latitude of the affiliation.  
Longitude Float 21,679,300 The longitude of the affiliation. 
Fips Integer 8,727,595 FIPS code of the county that includes the geocode. 
 
Table 9. Data type for records of Researcher_Employment. 
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Index Forma
t 
# of Lines with 
non-empty values 
Short description 
id Integer 532,356 Unique ID for each scholar’s employment instance. 
AND_ID Integer 532,356 Unique author ID allocated by AND. 
ORCID String 532,356 Unique researcher ID that distinguishes the researcher from others. 
Department String 426,597 The department which the researcher belongs to. 
BeginYear String 487,183 The beginning year of the researcher’s employment. 
Organization String 532,356 The institution which the researcher belongs to. 
City String 532,356 The city where the researcher works. 
Region String 363,066 The region where the researcher works. 
Country String 532,356 The country where the researcher works. 
Identifier String 392,562 The identifier of an organization. 
IdSource String 392,562 The provider of an organizations’ identifier. 
EndYear String 251,826 The end year of the researcher’s employment. 
 
Table 10. Data type for records of Researcher_Education. 
Index Forma
t 
# of Lines with 
non-empty values 
Short description 
id Integer 512,267 Unique ID for each scholar’s education instance. 
AND_ID Integer 512,267 Unique author ID allocated by AND.  
ORCID String 512,267 Unique researcher ID that distinguishes the researcher from others. 
BeginYear String 453,122 The beginning year of the researcher’s education. 
Organization String 512,267 The organization the researcher has been educated. 
City String 512,267 The city where the researcher works. 
Region String 378,188 The region where the researcher works. 
Country String 512,267 The country where the researcher works. 
Identifier String 410,239 The identifier of an organization.  
IdSource String 410,239 The provider of an organizations’ identifier. 
EndYear String 440,750 The end year of the researcher’s education. 
Role String 487,218 The degree that the researcher received. 
 
Table 11. Data type for records of NIH_Projects. 
Index Format # of Lines with 
non-empty values 
Short description 
id Integer 12,340,431 Unique ID for each project instance. 
AND_ID Integer 11,013,198 Unique author ID allocated by AND. 
PI_ID String 12,340,431 Unique PI ID allocated by NIH. 
PMID Integer 12,340,431 Unique ID assigned by PubMed to identify PubMed articles. 
ProjectNumber String 12,340,431 Project number of the current project. 
subProjectNumber String 9,438,420 Subproject number of the current project. 
PI_Name String 12,340,431 Full name of a PI.  
 
 Updating PKG is a complex task because it is subject to the update of different data sources 
and requires significant computation. In the future, we hope to refresh PKG quarterly based on 
PubMed updated files and updated datasets from other sources. We may also develop an 
integrative ontology to integrate all types of entities.  
 
Technical Validation 
Validity of Bio-Entity Extraction 
To validate the performance of the bio-entity extraction, we established BERT and the state-
of-the-art models as baselines. Then, we calculated the entity-level precision, recall, and F1 
scores of these models as evaluation metrics. The datasets and the test results of biomedical 
NER are presented in Table 12.  
Table 12. Test results of biomedical NER. 
Entity Type Datasets Metrics State-of-the-art 
BERT 
 (Wiki + Books) 
BioBERT 
 (+ PubMed + PMC) 
Disease NCBI disease40 
P % 86.41 84.12 89.04 
R % 88.31 87.19 89.69 
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F % 87.34 85.63 89.36 
2010 i2b2/VA41 
P % 87.44 84.04 87.50 
R % 86.25 84.08 85.44 
F % 86.84 84.06 86.46 
BC5CDR42 
P % 85.61 81.97 85.86 
R % 82.61 82.48 87.27 
F % 84.08 82.41 86.56 
Drug/Chemical 
BC5CDR42 
P % 94.26 90.94 93.27 
R % 92.38 91.38 93.61 
F % 93.31 91.16 93.44 
BC4CHEMD43 
P % 91.30 91.19 92.23 
R % 87.53 88.92 90.61 
F % 89.37 90.04 91.41 
Gene/Protein 
BC2GM44 
P % 81.81 81.17 85.16 
R % 81.57 82.42 83.65 
F % 81.69 81.79 84.40 
JNLPBA45 
P % 74.43 69.57 72.68 
R % 83.22 81.20 83.21 
F % 78.58 74.94 77.59 
Species 
LINNAEUS46 
P % 92.80 91.17 93.84 
R % 94.29 84.30 86.11 
F % 93.54 87.6 89.81 
Species·80047 
P % 74.34 69.35 72.84 
R % 75.96 74.05 77.97 
F % 74.98 71.63 75.31 
Average 
P % 85.38 82.61 85.82 
R % 85.79 84.00 86.40 
F % 85.53 83.25 86.04 
 
In Table 12, we report the precision (P), recall (R), and F1 (F) scores of each dataset. The 
highest scores are in boldface, and the second-highest scores are underlined. Sachan et al. (2017) 
48 reported the scores of the state-of-the-art models for the NCBI disease and BC2GM datasets, 
presented in Table 10. Moreover, the scores for the 2010 i2b2/VA dataset were obtained from 
Zhu et al. (2018)49 (single model), and the scores for the BC5CDR and JNLPBA datasets were 
obtained from Yoon et al. (2018) 13. The scores for the BC4CHEMD dataset were obtained 
from Wang et al. (2018) 50, and scores for the LINNAEUS and Species-800 datasets were 
obtained from Giorgi and Bader (2018)51. 
According to Table 12, BERT, which is pre-trained on the general domain corpus, was 
highly effective. On average, the state-of-the-art models outperformed BERT by 2.28% in 
terms of the F1 score. However, BioBERT obtained the highest F1 score in recognizing 
Genes/Proteins, Diseases, and Drugs/Chemicals. It outperformed the state-of-the-art models by 
0.51% in terms of the F1 score, on average.   
Validity of Multi-type Entity Normalization 
We used the multi-type normalization model to assign unique IDs to synonymous entities. 
Table 13 presents the performance of the multi-type entity normalization model.  
 
Table 13. Performance of the multi-type normalization model. 
Entity type 
Normalization 
model 
Test sets 
Precision 
% 
Recall % F1 score % Accuracy % 
Gene/Protein GNormPlus 
BC2 Gene Normalization, 
human species52 
87.1 86.4 86.7 - 
BC3 Gene Normalization, 
multispecies53 
- - 50.1 - 
Disease 
Sieve-based 
entity linking 
ShARe/CLEF eHealth 
Challenge corpus54 
- - - 90.75 
NCBI disease - - - 84.65 
Mutation tmVar 2.0 
OSIRISv1.255 97.20 80.62 88.14 - 
Thomas56 89.94 88.24 89.08 - 
Species 
Dictionary 
lookup of 
BioCreative III GN58 - - 46.91 - 
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SR4GN57 
Note: There are empty cells in the table because GNormPlus and tmVar 2.0 did not report their accuracies, the sieve-based 
entity linking model only reported its accuracy, and SR4GN only reported its F1 score. The authors of tmChem did not report the 
normalization performance of tmChem independently, so there were no performance data for Drug/Chemical. 
 
As shown in Table 13, with respect to genes and proteins, there were 75 different species 
in the BC3 Gene Normalization (BC3GN) test set, but GNormPlus focused only on seven of 
these species. Consequently, GNormPlus achieved a considerably lower F1 score of 36.6% on 
the multispecies test set (BC3GN) than on the human species test set (BC2GN). For mutations, 
tmVar 2.0 achieved F1 scores close to 90% on two corpora: OSIRISv1.2 and the Thomas corpus. 
Validity of Author Name Disambiguation 
The validation of author disambiguation remains a challenge because there is a lack of abundant 
validation sets. We applied a method using the NIH ExPORTER-provided information on NIH-
funded researchers to evaluate the precision, recall, and F1 measures of the author 
disambiguation59.  
NIH ExPORTER provides information about the principal investigator ID (PI_ID) for each 
scholar who received NIH funding between 1985 and 2018. Because applicants established a 
unique PI_ID and used the PI_ID across all grant applications, these PI_IDs have extremely 
high fidelity. NIH ExPORTER also provides article PMIDs as project outputs, which can be 
conveniently used as a connection between PI_IDs and AND_ID.  
We confirmed the bibliographic information of the NIH-funded scientists who received 
NIH funding during the years 1985–2018. Our AND evaluation steps were as follows: First, 
we collected project data for the years 1981–2018 in NIH ExPORTER, including 304,782 
PI_ID records and the corresponding 331,483 projects. Secondly, we matched the projects to 
articles acknowledging support by the grant, which were also recorded in the NIH ExPORTER 
dataset. We matched 214,956 of the projects to at least one article and identified 1,790,949 
articles funded by these projects. Some of these projects (116,527) did not match articles and 
were excluded. Because the NIH occasionally awards a project to a team that includes more 
than one PI, we eliminated the 13,154 records that contained multiple PIs because they could 
result in uncertain credit allocation. Consequently, our relevant set of PIs decreased to 147,027 
individuals associated with 1,749,873 articles and 201,802 projects.  
We then connected NIH PI_IDs from NIH ExPORTER to AND_IDs using the article 
PMIDs and author (PI)’s last name plus the initials as a crosswalk. This step resulted in 
1,400,789 unique articles remaining, associated with 109,601 PI_IDs and 107,380 AND_IDs. 
Finally, we computed precision (P) based on the number of articles associated with the most 
frequent AND_ID-to-PI_ID matched over the number of all articles associated with a specific 
AND_ID60. Furthermore, we computed recall (R) based on the number of articles associated 
with the most frequent PI_ID-to-AND_ID matched over the number of all articles associated 
with a particular PI_ID60. Figure 3 summarizes the precision, recall, and F1 calculations.  
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Figure 3. Calculation of Precision, Recall, and F1 Score 
 
Table 14 illustrates the precision, recall, and F1 scores for Author-ity, Semantic Scholar, 
and our integrated AND result. 
Table 14. Evaluation results of AND. 
 Precision Recall F1 score 
Author-ity 99.43% 96.92% 98.16% 
Semantic Scholar 96.24% 97.66% 96.94% 
AND Integration 98.62% 97.56% 98.09% 
  
As presented in Table 14, after integrating the AND results of Author-ity and Semantic 
Scholar, we obtained a high-quality integrated AND result that outperformed Semantic Scholar 
by 1.15% in terms of the F1 score and had more comprehensive coverage (until 2018) than 
Author-ity (until 2009).   
The evaluation results of AND might be slightly overestimated. The PIs of NIH grants 
usually have many publications over a long period and might be more likely to have rich 
information, such as affiliations and email addresses, about publications. Therefore, it should 
be easier to acquire higher performance on AND tasks than that of new entrants who published 
fewer papers and may lack of sufficient information for AND. Furthermore, approximately 1.15% 
of the author instances cannot be disambiguated since they do not exist in the Author-ity or 
Semantic Scholar AND results, which further slightly reduces the performance of AND results 
theoretically. However, the Semantic Scholar AND results and the AND Integration are 
evaluated based on the same baseline dataset with Author-ity in this section, and the evaluation 
of Author-ity performance using a random sample of articles indicates reliable high quality: the 
recall of the Author-ity dataset is 98.8%, the lumping (putting two different individuals into the 
same cluster) of the Author-ity dataset affects 0.5% of the clusters, and the splitting (assigning 
articles written by the same individual to more than one cluster) of the Author-ity dataset affects 
2% of the articles5. Consequently, we believe these factors have a limited impact on AND 
performance. 
Usage Notes 
Networking and collaboration have been associated with faculty promotions in academic 
medical centers61. Barriers exist for identifying researchers working on common bio-entities to 
facilitate collaboration. It is a challenge even at a single academic institution to identify 
potential collaborators who are working on the same bio-entities. This has led to many 
institution-specific projects profiling the faculty associated with the topics that they are 
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studying.62–65 The challenge is exacerbated when we search across multiple institutions.  
Researchers, academic institutions, and the pharmaceutical industry often face the 
challenge of identifying researchers working on a specific bio-entity. A traditional 
bibliographic database specializes only in returning an enormous number of related articles for 
particular keyword or term searches. Bio-entity profiling for researchers offers an advantage 
over this traditional approach by identifying specific connections between bio-entities and 
disambiguated authors, in which bio-entity profiling for researchers can directly locate the core 
specialists whose research is focused on these bio-entities. Furthermore, a bipartite author-
entity network projection analysis can identify a specific author’s neighborhood with similar 
research interest, which is crucial for community detection and collaborative commendation. 
We sought to use the PKG dataset to understand the trends over time of researcher-centric 
and bio-entity-centric activity by the following use cases: (1) researcher-centric for Stephen 
Silberstein, MD, a neurologist and expert in headache research;  (2) calcitonin Gene-Related 
Peptide (CGRP), a target of inhibition for one of the newest therapeutics in migraine treatment; 
and (3) bipartite author-entity projection network analysis for coronavirus, a disease that causes 
respiratory illness with symptoms such as a fever, cough, and difficulty breathing. 
For researcher-centric and bio-entity-centric activities, we collected 455 articles with Dr. 
Silberstein as an author and 7,877 articles on CGRP in the PKG dataset from 1970 to 2018 and 
extracted the bio-entities from these articles. Several publications and bio-entities were used 
for profiling the career of Dr. Silberstein. Several publications and the author’s distribution 
were used for profiling CGRP. For bipartite author-entity projection network analysis, we 
collected 9,778 articles on coronavirus in the PKG dataset from 1969 to 2019.  
 
Researcher-Centric Activity 
For Dr. Silberstein, 539 bio-entities, including 342 diseases, 142 drugs, 24 genes, 17 species, 
and 14 mutations, were extracted from 455 articles. As depicted in Figure 4(a), “Headache” and 
“migraine” were his two most studied diseases, reaching 21 and 19 articles, respectively, in 
2004. We trended his research over time on triptans, starting with sumatriptan. CGRP began to 
emerge in his publications starting in 2015. We noted the five researchers that have collaborated 
with Dr. Silberstein through his career and map with PKG their collaborations, interactions, 
and institutions over time. Visualizing the profiles of individual researchers can help to 
understand the trends in their topics of interest and collaboration patterns to enable an 
understanding of collaboration factors that may be associated with academic success or 
scientific discovery.  
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Figure 4. Trends over time of researcher-centric and bio-entity-centric activity 
 
Bio-Entity-Centric Activity 
For CGRP, there are currently 7,877 articles by 32,392 authors on CGRP dating back to 1982. 
Figure 4(b) illustrates that there was a dramatic increase in the number of CGRP-related articles, 
from 13 in 1982 to 1,209 in 1991, with a steady increase to 1,517 in 2018. The trend of the 
number of authors over time was similar to that of the volume of articles on CGRP.  
As we demonstrated with a previous analysis of the repurposing of Aspirin66-67, we observe 
research on CGRP starting at approximately the same time as the research on triptans for the 
treatment of migraines. Research on the pathophysiology of migraines identified a central role 
of the neuropeptide calcitonin gene-related peptide (CGRP), which is thought to be involved 
with the dilation of cerebral and dural blood vessels, release of inflammatory mediators, and 
the transmission of pain signals68. Research on the mechanism of the action of triptans—
serotonin receptor agonists—has led to an understanding that they normalize elevated CGRP 
levels, which among other mechanisms, has led to an improvement in migraine headache 
symptoms. Consequently, papers in high-impact journals have called for identifying molecules 
and the development of drugs to directly inhibit CGRP69, which has since led to the 
development of CGRP inhibitors as a new class of migraine treatment medications. 
Bipartite Author-Entity Network 
A total of 28,223 disambiguated authors and 5,379 distinct bio-entities of coronavirus articles 
were used to construct author-bio-entity bipartite network. Figure 5 illustrated the bipartite 
network (Figure 5(a)) and its author projection (Figure 5(b)) and bio-entity projection (Figure 
5(c)). In Figure 5(a), the author vertices are blue, and the bio-entity vertices are pink. A link 
between a bio-entity and an author exists if and only if this bio-entity has been researched by 
that author. Connections between two authors or between two bio-entities are not allowed. The 
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edge weight is set as the number of papers an author published that mention a bio-entity. In 
Figure 5(b) and 5(c), the edge weight is set as the number of common neighbors for the author 
and bio-entity, respectively. Vertices are marked with different colors to show their community 
attribution.   
 
 
Figure 5. Bipartite network analysis of coronavirus 
 
Figure 5(a) illustrates a distinct relationship between authors and their focused bio-entities. 
For example, the disease SARS have been frequently studied by author Baric R S, Yuen Kwok-
Yung, and Zheng Bo-Jian. In addition to SARS, Baric R S is also interested in coronavirus 
infection and HBV infection. Figure 5(b) depicts the common research interest relationship 
between authors. Strong connections between authors may indicate that they collaborated 
multiple times, such as Chan Kwok Hung and Yuen Kwok-Yung, who published 69 papers 
together. These connections may also indicate author pairs that have similar research interests 
but never collaborated, such as Baric R S and Yuen Kwok-Yung, which is crucial for the 
collaborative commendation. Similarly, those connections between bio-entities in Figure 5(c) 
indicate that they have been studied by authors with similar research interests, which can be 
further applied to discover the hidden relations between bio-entities.  
 
Code Availability 
We have made the pre-trained weights of BioBERT freely available at 
https://github.com/naver/biobert-pretrained, and the source code for fine-tuning BioBERT 
available at https://github.com/dmis-lab/biobert. 
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